Etoiles Capital Group Co., Ltd Announces Closing of Underwriters' Over-Allotment Option in Connection with Initial Public Offering — Neutral
EFTY GlobeNewsWire — August 13, 2025HONG KONG, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Etoiles Capital Group Co., Ltd (Nasdaq: EFTY), a Hong Kong-based financial services provider, today announced that it closed the sale of an additional 210,000 Class A ordinary shares of the Company, pursuant to the full exercise of the underwriters' over-allotment option granted in connection with the Company's initial public offering (“IPO”, together with such over-allotment closing, the “Offering”), at the IPO price of $4.00 per share, less underwriting discounts. As a result, the Company has raised aggregate gross proceeds of $6,440,000, including the previously announced IPO gross proceeds of $5,600,000, prior to …
Gold, silver gain amid weaker USDX, dip in bond yields — Positive
AAAU BAR DBP DGL GLD GLDM IAU OUNZ SGOL SIL SILJ SIVR SLV SLVP UGL Kitco — August 13, 2025Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.
CoreWeave, Inc. reported Q2 results, causing the stock to crash more than 9% in pre-market on wider than expected loss in spite of a revenue beat. The reality for CoreWeave's business model is that growth will come at the expense of a deepening net loss. Operating expenses nearly quadrupled from a year ago this quarter. We don't mind higher operating expense if the backlog growth matches, so that's what we're keeping an eye after backlog grew 86% Y/Y and 16% sequentially to $30.1B.
Fmr. FTC Commissioner: Perplexity is another company trying to capitalize on Google's antitrust woes — Positive
GOOG GOOGL CNBC Television — August 13, 2025Mozelle Thompson, former FTC commissioner, joins CNBC's 'Squawk on the Street' to discuss Perplexity's bid for Google's Chrome.
Cisco Systems Earnings Preview: Will AI Help The Company Grow? — Neutral
CSCO Forbes — August 13, 2025Cisco Systems Inc. is scheduled to report earnings after Wednesday's close. The stock hit a record high of $82/share in March 2000 and is currently trading near $70/share.
Cava Group Stock Crumbles After Q2 Revenue Miss — Negative
CAVA Schaeffers Research — August 13, 2025Shares of CAVA Group Inc (NYSE:CAVA) are spiraling this morning, despite beating second-quarter earnings estimates with $0.16 per share.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Nutex Health Inc. - NUTX — Neutral
NUTX GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Nutex Health Inc. (“Nutex” or the “Company”) (NASDAQ: NUTX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Enterprise Products Partners Remains A Top Pick In Midstream — Positive
EPD Seeking Alpha — August 13, 2025Enterprise Products Partners remains a top pick in midstream due to strong cash flow, low leverage, and a high, reliable yield. Despite a recent share price dip, fundamentals are robust: rising profits, growing cash flows, and attractive valuation versus peers. Management is driving future growth through $6 billion in capital projects and strategic acquisitions to capture rising U.S. hydrocarbon demand.
Enterprise Products Up 16% in a Year: Should Investors Still Chase it? — Positive
EPD Zacks Investment Research — August 13, 2025EPD's 16% surge in a year is backed by major midstream projects, but rising competition may slow its export gains.
RBLX Stock Trades at Premium Value: Should You Buy, Sell or Hold? — Positive
RBLX Zacks Investment Research — August 13, 2025Roblox's soaring growth and viral hits drive record engagement. However, high costs, losses and a rich valuation raise caution.
Rosen Law Firm Encourages LifeMD, Inc. Investors to Inquire About Securities Class Action Investigation – LFMD — Neutral
LFMD Business Wire — August 13, 2025NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of LifeMD, Inc. (NASDAQ: LFMD) resulting from allegations that LifeMD may have issued materially misleading business information to the investing public. So What: If you purchased LifeMD securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rose.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of MarineMax, Inc. – HZO — Neutral
HZO GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of MarineMax, Inc. (“MarineMax” or the “Company”) (NYSE: HZO). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
E.L.F. Cosmetics slammed for hiring controversial comedian Matt Rife in new ad — Negative
ELF New York Post — August 13, 2025The legal-themed advertisement builds on a Superbowl 2024 campaign, and sees Heidi N Closet and Rife try to defend their clients from overpriced beauty products.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Dow Inc. – DOW — Neutral
DOW GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Dow Inc. (“Dow” or the “Company”) (NYSE: DOW). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Alico, Inc. (NASDAQ:ALCO ) Q3 2025 Earnings Call August 13, 2025 8:30 AM ET Company Participants Bradley Heine - Chief Financial Officer & Accounting Officer John E. Kiernan - President, CEO & Director Conference Call Participants Brandon B.
TOST Skyrockets 78% in a Year: How Should You Play the Stock? — Positive
TOST Zacks Investment Research — August 13, 2025Toast's 78% surge in a year highlights strong growth and innovation, but lofty valuation and macro headwinds loom large.
Franklin Touches 52-Week High: How to Play the Stock Now? — Neutral
BEN Zacks Investment Research — August 13, 2025BEN hits a 52-week high on strong AUM growth, acquisitions and solid capital returns but rising expenses pose risks ahead.
Should You Stay Invested in or Sell Nebius Stock Post Q2 Earnings? — Negative
NBIS Zacks Investment Research — August 13, 2025NBIS posts massive Q2 growth and ups ARR forecast, but faces stiff competition, high spending and scaling risks ahead.
Franco-Nevada: Best-In-Class Gold Royalty Player, Not A Bargain Today — Positive
FNV Seeking Alpha — August 13, 2025Franco-Nevada Corporation posted record Q2 revenue and earnings, driven by historic gold prices, strong portfolio performance, and industry-leading margins. Valuation remains at a significant premium, reflecting market confidence but leaving limited short-term upside. Diversification across gold, PGM, and energy assets provides resilience against single-commodity volatility.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Telix Pharmaceuticals Limited – TLX — Neutral
TLX GlobeNewsWire — August 13, 2025NEW YORK, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited (“Telix” or the “Company”) (NASDAQ: TLX). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.